| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2003 | CN1098843C Isoxazoles |
| 01/15/2003 | CN1098841C Novel amide derivatives and medicinal compositions thereof |
| 01/15/2003 | CN1098839C Preparation and application of 80-chloroquinolone carboxylic acid derivative |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/15/2003 | CN1098707C Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose |
| 01/15/2003 | CN1098687C Use of aminopurine antiviral agents for treatment and prophylaxis of latent herpesvirus infections |
| 01/15/2003 | CN1098686C Use of xanthine derivatives for reducing pathological hyper-reactivity of eosinophilic granulocytes, xanthine compounds and process for producing them |
| 01/15/2003 | CN1098685C Rifampin film and preparing method and use thereof |
| 01/15/2003 | CN1098684C Orally administerable pharmaceutical formulations |
| 01/15/2003 | CN1098683C Application of scutellaria baicalensis glucoside as germicide for skin and mucosa |
| 01/15/2003 | CN1098682C Pharmaceutical process of crocus sativus polyglycoside and its tablets |
| 01/15/2003 | CN1098681C Oil-in-water emulsion and its use and medicinal composition containing it |
| 01/15/2003 | CN1098680C Suspending liquid for spray and preparing method thereof |
| 01/14/2003 | US6506937 Used as antiarrhythmics |
| 01/14/2003 | US6506928 Derivative in which fullerene is linked to at least one dendron having at least one protic group which imparts water solubility |
| 01/14/2003 | US6506917 Ligands which are more selective for retinoid X receptor than is retinoic acid |
| 01/14/2003 | US6506912 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 01/14/2003 | US6506911 Pyrano [3,2-d]-1,3-dioxin-8 ones |
| 01/14/2003 | US6506901 1-(9H-Carbazol-4-yloxy)-3-((1-(7-trifluoromethyl-quinolin-4-yl) -piperidin-4-lmethyl)-amino)-propan-2-ol, for example; treating diabetes, urinary continence, atherosclerosis, gastrointestinal disorders, glaucoma |
| 01/14/2003 | US6506886 Treating with mixture of water and immiscible solvent; isolation by filtration; crystallization |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506803 Methods of preventing and treating microbial infections |
| 01/14/2003 | US6506802 Disulfide derivatives useful for treating allergic diseases |
| 01/14/2003 | US6506801 Methods of treating anosmia and repopulating olfactory nerves with retinoids |
| 01/14/2003 | US6506799 Treating or preventing a cardiovascular disease in a patient, comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of 6-(6-hydroxy-5,5-dimethylhexyloxy)-2,2-dimethyl-hexan-1-ol and |
| 01/14/2003 | US6506797 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) α |
| 01/14/2003 | US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of |
| 01/14/2003 | US6506792 Breast and endometrial cancers are major causes of death in Western women. In particular, tumours in endocrine-dependent tissues, such as the breast and endometrium, occur most frequently in postmenopausal women at a time when the ovaries |
| 01/14/2003 | US6506791 Method of treatment of protozoan infections in fish |
| 01/14/2003 | US6506790 Compounds and methods |
| 01/14/2003 | US6506789 Methods for the treatment of itching comprising administering PGD2 receptor antagonist |
| 01/14/2003 | US6506788 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 01/14/2003 | US6506787 Aids therapy |
| 01/14/2003 | US6506785 Establishing the status of the mammal as presently or prospectively being in early stages of degeneration of articular cartilage or subchondral bone in one or more joinsts, administering a xanthine chondroprotective compound |
| 01/14/2003 | US6506783 A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals and can be used to treat viral infections that comprises a fungicide is disclosed. The particular fungicide used is a benzimidazole derivative |
| 01/14/2003 | US6506782 Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/14/2003 | US6506781 Prevent formation of a hydrogen bond between the agonist and tyrosine or histidine, or tryptophan involved in receptor activation; and/or b) displace the tyrosine or histidine, or tryptophan involved in receptor activation from its agonist |
| 01/14/2003 | US6506780 Benzophenones and sulfones as inhibitors of glycine uptake |
| 01/14/2003 | US6506779 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 01/14/2003 | US6506778 Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals |
| 01/14/2003 | US6506775 Substituted benzylaminopiperidine compounds |
| 01/14/2003 | US6506774 The use of orexin receptor antagonists as neuroprotectants, and in the treatment of nausea and vomiting, irritable bowel syndrome and other conditions associated with visceral pain. |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506772 Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. |
| 01/14/2003 | US6506771 Anticoagulants |
| 01/14/2003 | US6506770 Antiviral compounds |
| 01/14/2003 | US6506768 Tetrahydro γ-carbolines |
| 01/14/2003 | US6506766 Glucocortiocoid-selective antinflammatory agents |
| 01/14/2003 | US6506765 Apomorphine derivatives and methods for their use |
| 01/14/2003 | US6506762 Certain alkylene diamine-substituted heterocycles |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | US6506757 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 01/14/2003 | US6506756 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 01/14/2003 | US6506755 Thiazolidinecarboxyl acids |
| 01/14/2003 | US6506753 Anxiolytic agents, anticonvulsants |
| 01/14/2003 | US6506750 Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/14/2003 | US6506748 Aromatic heterocyclic compounds as antiinflammatory agents |
| 01/14/2003 | US6506747 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; |
| 01/14/2003 | US6506746 Such as Alzheimer's disease, by administering olanzapine or salt thereof |
| 01/14/2003 | US6506742 Adding a contraceptive to ethyl alcohol, then adding a low molecular weight polyethylene glycol, and then adding water to give specified dosage; bioavailability, stability; useful as a reference standard |
| 01/14/2003 | US6506741 Remedies for glomerulosclerosis |
| 01/14/2003 | US6506740 Compounds that can be substituted at the 7, 8, and/or 9 positions and methods for preparing the 4- dedimethylamino tetracycline compounds. Other tetracycline compounds are the 4-dedimethylaminotetracycline derivatives with an oxime |
| 01/14/2003 | US6506739 Compounds possess anti-tumor activities or are capable of being modified to have anti-tumor activities; and this invention relates to the use of the compounds in methods for the treatment of tumors and, especially, for the treatment of |
| 01/14/2003 | US6506736 A method of treating a human being having or suspected of having sexual dysfunction or a disorder of physiological and/or anatomical response to sexual stimulation, said dysfunction or disorder involving erectile tissue of |
| 01/14/2003 | US6506735 Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences |
| 01/14/2003 | US6506591 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 01/14/2003 | US6506587 Nucleotide sequences coding enzymatic polypeptide; for use as an antitumor a gents |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506572 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy |
| 01/14/2003 | US6506555 Use of HIV protease inhibiting compounds |
| 01/14/2003 | US6506420 Combinations of psyllium and chitosan for synergistic adsorption of triglyceride |
| 01/14/2003 | US6506419 Containing amino acid having a hydroxyl group or a dipeptide containing said amino acid; food, beverage; prevention of discoloration by oxidative polymerization |
| 01/14/2003 | US6506412 Treatment of dry eye syndrome |
| 01/14/2003 | US6506411 Anti-angiogenic compositions and methods of use |
| 01/14/2003 | US6506408 Implantable or insertable therapeutic agent delivery device |
| 01/14/2003 | US6506399 Controlled release implantable drug delivery system composed of a plurality of botulinum toxin-incorporating polymeric microspheres. |
| 01/14/2003 | US6506393 Methods of treating protozoal diseases |
| 01/14/2003 | US6506390 Progestogen-anti-progestogen regimens |
| 01/14/2003 | US6506388 Treating pollinosis using substance obtained by dissolving cell wall of corynebacterlum glutamicum with one of glucosi-dase and endopeptidase in isotonic solution medium, separa-ting protoplasts and treating with the other enzyme |
| 01/14/2003 | US6506387 Method for preparing aloin by extraction |
| 01/14/2003 | US6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies |
| 01/14/2003 | US6506380 Methods of preventing or treating allergies |
| 01/14/2003 | CA2294928C Production of avermectin compounds |
| 01/14/2003 | CA2288760C Ascorbyl-phosphoryl-cholesterol |
| 01/14/2003 | CA2249501C Method of preparing and using isoflavones |
| 01/14/2003 | CA2246758C Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 01/14/2003 | CA2222303C Use of at least one no synthase inhibitor for treating sensitive skin |
| 01/14/2003 | CA2217516C Triazole antifungal agent |
| 01/14/2003 | CA2217477C Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/14/2003 | CA2183971C Ready-to-eat cereal products fortified with ferric edta |
| 01/14/2003 | CA2116859C Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
| 01/14/2003 | CA2093258C Cytarabine ocfosfate hard capsule |
| 01/14/2003 | CA2067975C Buffered matrix aspirin tablet |
| 01/14/2003 | CA2065270C Erection-inducing methods and compositions |
| 01/13/2003 | WO2002006237A1 Medicine comprising dicyanopyridine derivative |
| 01/13/2003 | CA2415899A1 Medicine comprising dicyanopyridine derivative |
| 01/13/2003 | CA2393376A1 Assay methods |
| 01/10/2003 | CA2392841A1 Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea |
| 01/09/2003 | WO2003003006A2 New potent, selective and non toxic c-kit inhibitors |
| 01/09/2003 | WO2003003004A2 Method for identifying compounds the specifically deplete mast cells |